uniQure N.V.

QURE ·Healthcare, Drug Manufacturers - General
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $16.1M $27.1M $15.8M $106.5M $524.0M $37.5M $7.3M $11.3M
Cost of Revenue $1.7M $1.3M $65.0K $1.3M $25.0M $2.9M $1.7M $1.2M
Gross Profit $14.4M $25.9M $15.8M $105.2M $499.0M $34.6M $5.6M $10.1M
Gross Margin 89.5% 95.3% 99.6% 98.8% 95.2% 92.3% 77.3% 89.3%
Operating Expenses
Research & Development $140.7M $143.8M $214.9M $197.6M $143.5M $122.4M $94.7M $74.8M
SG&A Expense $65.5M $52.7M $74.6M $55.1M $56.3M $42.6M $33.5M $25.3M
Operating Income $-185.3M $-184.3M $-282.9M $-143.2M $310.6M $-125.4M $-121.1M $-88.2M
Operating Margin -1,151.4% -679.6% -1,785.5% -134.4% 59.3% -334.3% -1,663.8% -781.9%
Interest Expense $41.6M $11.7M $7.5M $3.8M $3.8M $2.2M
Pretax Income $-193.3M $-237.1M $-306.6M $-128.3M $332.8M $-141.4M $-124.2M $-83.1M
Income Tax Expense $5.6M $2.4M $1.9M $-1.5M $3.2M $-16.4M $231.0K
Net Income $-199.0M $-239.6M $-308.5M $-126.8M $329.6M $-125.0M $-124.2M $-83.3M
Net Margin -1,236.0% -883.4% -1,947.1% -119.1% 62.9% -333.3% -1,705.8% -738.2%
EPS (Basic) $-3.46 $-4.92 $-6.47 $-2.71 $7.17 $-2.81 $-3.11 $-2,340.00
EPS (Diluted) $-3.46 $-4.92 $-6.47 $-2.71 $7.04 $-2.81 $-3.11 $-2,340.00
Shares Outstanding (Basic) 57.5M 48.6M 47.7M 46.7M 46.0M 44.5M 40.0M 37.4M
Shares Outstanding (Diluted) 57.5M 48.6M 47.7M 46.7M 46.8M 44.5M 40.0M 37.4M
Dividends Per Share
← Newer Page 1 of 2 Older →